Stay updated on Pembrolizumab Combo Clinical Trial in Advanced NSCLC
Sign up to get notified when there's something new on the Pembrolizumab Combo Clinical Trial in Advanced NSCLC page.

Latest updates to the Pembrolizumab Combo Clinical Trial in Advanced NSCLC page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedThe clinical trial record was updated on 2026-10-29, with changes to its study status and contact/location information.SummaryDifference0.2%

- Check20 days agoChange DetectedA notice was added explaining that NIH content may use “Super Intelligence” (SI) in place of “Artificial Intelligence” (AI) during a terminology transition.SummaryDifference0.3%

- Check27 days agoChange DetectedThe ClinicalTrials.gov page footer now displays software revision v3.7.2 instead of v3.7.1.SummaryDifference0.0%

- Check34 days agoChange DetectedThe footer’s ClinicalTrials.gov revision identifier changed from v3.7.0 to v3.7.1.SummaryDifference0.0%

- Check55 days agoChange DetectedOn the Study Record History page, the UI now shows 'Find contact information' and the revision stamp updated to 'Revision: v3.7.0', replacing the previous 'Find Contact Information' and 'Revision: v3.6.6'.SummaryDifference0.1%

- Check77 days agoChange DetectedThe update adds the new Study Status and Contacts/Locations sections to the study history, providing current status and contact details. The page revision has been bumped to v3.6.6 to reflect this update.SummaryDifference0.2%

Stay in the know with updates to Pembrolizumab Combo Clinical Trial in Advanced NSCLC
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab Combo Clinical Trial in Advanced NSCLC page.